Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma

Aim: We aimed to compare the survival outcomes of radiofrequency ablation (RFA) and surgical resection (SR) for patients with small early-stage primary intrahepatic cholangiocarcinoma (ICC).Methods: Patients with small (≤5 cm) and early-stage ICC were screened from the Surveillance, Epidemiology, an...

Full description

Bibliographic Details
Main Authors: Xin Xiang, Daixing Hu, Zheng Jin, Pan Liu, Huapeng Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.540662/full
id doaj-bdc3842e38794fb3ac337377d85ccccc
record_format Article
spelling doaj-bdc3842e38794fb3ac337377d85ccccc2020-11-25T03:12:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-09-011010.3389/fonc.2020.540662540662Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic CholangiocarcinomaXin Xiang0Daixing Hu1Zheng Jin2Pan Liu3Huapeng Lin4Department of Hepatobiliary Surgery, The First People's Hospital of Neijiang, Neijiang, ChinaDepartment of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Gastroenterology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Hepatobiliary Surgery, The First People's Hospital of Neijiang, Neijiang, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaAim: We aimed to compare the survival outcomes of radiofrequency ablation (RFA) and surgical resection (SR) for patients with small early-stage primary intrahepatic cholangiocarcinoma (ICC).Methods: Patients with small (≤5 cm) and early-stage ICC were screened from the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and cancer-specific survival (CSS) rates between the SR and RFA patients were evaluated. The results were verified using an inverse probability-weighting model (IPTW).Results: In total, 184 patients with small T1 stage ICC that received RFA or SR treatment were identified. The OS rates at 1, 3, and 5 years were 87.4, 73.3, and 61.5% for patients who underwent SR, respectively, and 89.9, 42.4, and 23.9%, respectively, for patients who received RFA. CSS rates at 1, 3, and 5 years were 91.5, 73.8, and 66.1%, respectively, for the SR group and 93.5, 53.4, and 30.0%, respectively, for the RFA group. The OS and CSS rates were evaluated to be significantly better in the SR group than in the RFA group after the multivariate Cox regression and IPTW analysis. Subsequently, the survival benefit of SR was also observed in the subgroup of patients with <4.5 or <4 cm early-stage ICC when compared with RFA.Conclusion: Our results indicated that the SR provided a significantly better prognosis than RFA in patients with small and early-stage ICC. SR as the first-line treatment of primary early-stage ICC is still recommended. However, prospective randomized controlled trials with larger sample sizes are required to compare these modalities in the treatment of ICC.https://www.frontiersin.org/article/10.3389/fonc.2020.540662/fullradiofrequency ablationintrahepatic cholangiocarcinomaearly-stagesurvivalSEER
collection DOAJ
language English
format Article
sources DOAJ
author Xin Xiang
Daixing Hu
Zheng Jin
Pan Liu
Huapeng Lin
spellingShingle Xin Xiang
Daixing Hu
Zheng Jin
Pan Liu
Huapeng Lin
Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
Frontiers in Oncology
radiofrequency ablation
intrahepatic cholangiocarcinoma
early-stage
survival
SEER
author_facet Xin Xiang
Daixing Hu
Zheng Jin
Pan Liu
Huapeng Lin
author_sort Xin Xiang
title Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
title_short Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
title_full Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
title_fullStr Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
title_full_unstemmed Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma
title_sort radiofrequency ablation vs. surgical resection for small early-stage primary intrahepatic cholangiocarcinoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-09-01
description Aim: We aimed to compare the survival outcomes of radiofrequency ablation (RFA) and surgical resection (SR) for patients with small early-stage primary intrahepatic cholangiocarcinoma (ICC).Methods: Patients with small (≤5 cm) and early-stage ICC were screened from the Surveillance, Epidemiology, and End Results (SEER) database. Overall survival (OS) and cancer-specific survival (CSS) rates between the SR and RFA patients were evaluated. The results were verified using an inverse probability-weighting model (IPTW).Results: In total, 184 patients with small T1 stage ICC that received RFA or SR treatment were identified. The OS rates at 1, 3, and 5 years were 87.4, 73.3, and 61.5% for patients who underwent SR, respectively, and 89.9, 42.4, and 23.9%, respectively, for patients who received RFA. CSS rates at 1, 3, and 5 years were 91.5, 73.8, and 66.1%, respectively, for the SR group and 93.5, 53.4, and 30.0%, respectively, for the RFA group. The OS and CSS rates were evaluated to be significantly better in the SR group than in the RFA group after the multivariate Cox regression and IPTW analysis. Subsequently, the survival benefit of SR was also observed in the subgroup of patients with <4.5 or <4 cm early-stage ICC when compared with RFA.Conclusion: Our results indicated that the SR provided a significantly better prognosis than RFA in patients with small and early-stage ICC. SR as the first-line treatment of primary early-stage ICC is still recommended. However, prospective randomized controlled trials with larger sample sizes are required to compare these modalities in the treatment of ICC.
topic radiofrequency ablation
intrahepatic cholangiocarcinoma
early-stage
survival
SEER
url https://www.frontiersin.org/article/10.3389/fonc.2020.540662/full
work_keys_str_mv AT xinxiang radiofrequencyablationvssurgicalresectionforsmallearlystageprimaryintrahepaticcholangiocarcinoma
AT daixinghu radiofrequencyablationvssurgicalresectionforsmallearlystageprimaryintrahepaticcholangiocarcinoma
AT zhengjin radiofrequencyablationvssurgicalresectionforsmallearlystageprimaryintrahepaticcholangiocarcinoma
AT panliu radiofrequencyablationvssurgicalresectionforsmallearlystageprimaryintrahepaticcholangiocarcinoma
AT huapenglin radiofrequencyablationvssurgicalresectionforsmallearlystageprimaryintrahepaticcholangiocarcinoma
_version_ 1724650718441242624